Stock & Company Details
Biohaven Pharmaceutical Holding Company Ltd $BHVN
Price:
N/A
N/A
151M
$2.3B
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.91
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BHVN technical indicators
Latest Biohaven Pharmaceutical Holding Company Ltd (BHVN) indicator readings as of 2026-10-29.
BHVN's 14-day RSI is 69.2, in neutral territory. At $16.49 it is trading 35.1% above its 200-day moving average of $12.21, and above its 50-day average of $13.58. Price sits above the upper Bollinger Band ($9.49 to $16.05). ADX reads 30.1, indicating a trending market.
Overview
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.
Finance Bot
Ask your questions
Start by typing a question below.
